---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-122264"
form_type: "8-K"
ticker: "IONQ"
cik: "0001824920"
company_name: "IonQ, Inc."
filed_at: "2024-11-06T23:59:59+00:00"
generated_at: "2026-05-30T04:46:39.273758+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# IonQ beats Q3 with $12.4M rev (+102% YoY), raises FY guide; $63.5M bookings; agrees to buy Qubitekk

## Summary
- Q3 revenue $12.4M (above guidance high end), +102% YoY from $6.1M.
- Full-year 2024 revenue guidance raised to $38.5M-$42.5M.
- Q3 bookings $63.5M, including largest U.S. quantum contract of $54.5M from AFRL.
- Definitive agreement to acquire Qubitekk, a quantum networking company.
- Partnerships with AstraZeneca (drug discovery), Ansys (CAE), and Univ. of Maryland.

## SEC filing metadata
- accession: 0000950170-24-122264
- form_type: 8-K
- ticker: IONQ
- cik: 0001824920
- company_name: IonQ, Inc.
- filed_at: 2024-11-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1824920/000095017024122264/0000950170-24-122264-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1824920/000095017024122264/ionq-20241106.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-122264
- JSON: https://secwatch.observer/filing/0000950170-24-122264.json
- Plain text: https://secwatch.observer/filing/0000950170-24-122264.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.